Anti-Parkinson’s Disease Drugs



Anti-Parkinson’s Disease Drugs















Table 23-1 Anti-Parkinson’s Disease Drugs



















Prototype Drug


Related Drugs


Drug Classification


biperiden (Akineton)


benztropine (Cogentin)


diphenhydramine (Benadryl)


procyclidine (Kemadrin)


trihexyphenidyl (Artane)


Anticholinergics


levodopa (Dopar)


amantadine (Symmetrel)


bromocriptine (Parlodel)


carbidopa-levodopa (Sinemet)


pergolide (Permax)


pramipexole (Mirapex)


ropinirole (Requip)


selegiline (Eldepryl


Dopaminergics


tolcapone (Tasmar)


entacapone (Comtan)


Catechol-o-methyl transferase (COMT) inhibitor



ANTI-PARKINSON’S DRUGS CLIENT TEACHING


Anticholinergics



  • Do not breast-feed.


  • Suck on hard candy and perform frequent mouth care if you experience dry mouth.


  • No activities requiring concentration until effects of drug are known


  • Drug dose may be increased as you develop tolerance to the drug over time.


  • Urinate before taking the drug if urinary retention is a problem.




COMT Inhibitors



  • No hazardous activities until drug response is known


  • No alcohol or sedative drugs


  • Change positions slowly.


  • Drug must not be stopped abruptly.



  • Do not breast-feed.


  • Notify physician of: fainting, hallucinations, severe diarrhea, increased loss of muscle control, or yellow eyes or skin.



Dopaminergics

Oct 21, 2016 | Posted by in NURSING | Comments Off on Anti-Parkinson’s Disease Drugs

Full access? Get Clinical Tree

Get Clinical Tree app for offline access